Shandong Luoxin Pharmaceutical Group Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
6,000
- Latest Deal Type
-
Reverse Merger
- Financing Rounds
-
4
- Investments
-
2
Shandong Luoxin Pharmaceutical Group General Information
Description
Operator of a pharmaceutical company. The company operates as a large-scale pharmaceutical enterprise group integrating drug research and development, manufacturing, trading with medical treatment and health services on therapeutic areas such as cardiovascular diseases, endocrinology, gastroenterology, respiratory diseases and oncology with the help of innovative medicines through in-licensing and strategic partnerships.
Contact Information
Website
www.luoxin.cnCorporate Office
- No. 18, Huxi Road
- National New and High-tech Industrial Development Zone
- Linyi, Shandong 276017
- China
Corporate Office
- No. 18, Huxi Road
- National New and High-tech Industrial Development Zone
- Linyi, Shandong 276017
- China
Shandong Luoxin Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shandong Luoxin Pharmaceutical Group Comparisons
Industry
Financing
Details
Shandong Luoxin Pharmaceutical Group Competitors (30)
One of Shandong Luoxin Pharmaceutical Group’s 30 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
| GSK | Corporation | London, United Kingdom |
Shandong Luoxin Pharmaceutical Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Shandong Luoxin Pharmaceutical Group Patents
Shandong Luoxin Pharmaceutical Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3889136-A1 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Active | 28-Nov-2018 | ||
| EP-3889136-A4 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Active | 28-Nov-2018 | ||
| EP-3889136-B1 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Active | 28-Nov-2018 | ||
| ES-3000862-T3 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Active | 28-Nov-2018 | ||
| US-12098127-B2 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Active | 28-Nov-2018 | C07D209/30 |
Shandong Luoxin Pharmaceutical Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Shandong Luoxin Pharmaceutical Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shandong Luoxin Pharmaceutical Group Investments (2)
Shandong Luoxin Pharmaceutical Group’s most recent deal was a Corporate with Luoxin Health Technology for . The deal was made on 20-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Luoxin Health Technology | 20-Apr-2022 | Corporate | Medical Supplies | ||
| Joint Venture (Helix Healthcare / Shandong Luoxin Pharmaceutical Group Stock Company) | 11-Dec-2018 | Joint Venture | Therapeutic Devices |
Shandong Luoxin Pharmaceutical Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Luoxin Health Technology | Beijing, China | 2020 |
Shandong Luoxin Pharmaceutical Group FAQs
-
When was Shandong Luoxin Pharmaceutical Group founded?
Shandong Luoxin Pharmaceutical Group was founded in 1996.
-
Where is Shandong Luoxin Pharmaceutical Group headquartered?
Shandong Luoxin Pharmaceutical Group is headquartered in Linyi, China.
-
What is the size of Shandong Luoxin Pharmaceutical Group?
Shandong Luoxin Pharmaceutical Group has 6,000 total employees.
-
What industry is Shandong Luoxin Pharmaceutical Group in?
Shandong Luoxin Pharmaceutical Group’s primary industry is Pharmaceuticals.
-
Is Shandong Luoxin Pharmaceutical Group a private or public company?
Shandong Luoxin Pharmaceutical Group is a Private company.
-
What is Shandong Luoxin Pharmaceutical Group’s current revenue?
The current revenue for Shandong Luoxin Pharmaceutical Group is .
-
How much funding has Shandong Luoxin Pharmaceutical Group raised over time?
Shandong Luoxin Pharmaceutical Group has raised $5.02M.
-
Who are Shandong Luoxin Pharmaceutical Group’s investors?
Luoxin Pharmaceuticals Group Stock, Ally Bridge Group, Giant Star Global, and GL Capital Group have invested in Shandong Luoxin Pharmaceutical Group.
-
Who are Shandong Luoxin Pharmaceutical Group’s competitors?
Novartis, Genentech, Merck & Co., Pfizer Manufacturing Austria, and GSK are some of the 30 competitors of Shandong Luoxin Pharmaceutical Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
